Precision Medicine Intervention in Severe Asthma (PRISM) Study

Status Recruiting

Clinical Trial Summary

The Korea-UK Precision Medicine Intervention in Severe Asthma (PRISM) study aims to identify molecular phenotypes of severe asthma by analyzing multi-omics data including genomics, epigenomics, transcriptomics, proteomics, metagenomics, and metabolomics.

Clinical Trial Description

This is a prospective, observational cohort study. The participants are composed of the patients having severe asthma treated with biologic agents or conventional medication. Once enrolled, regular evaluation of clinical characteristics and obtainment of samples for omics analysis is conducted to identify clinically relevance molecular signals in severe asthmatics. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05164939
Study type	Observational
Source	Asan Medical Center
Contact	Tae-Bum Kim
Phone	82-2-3010-3287
Email	tbkim@amc.seoul.kr
Status	Recruiting
Phase
Start date	May 1, 2020
Completion date	December 31, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05018299` - Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma	Phase 2
Recruiting	`NCT05472324` - Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.	Phase 2
Recruiting	`NCT04914078` - Severe Asthma Exacerbations and Mepolizumab Treatment
Completed	`NCT05576454` - Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects	Phase 1
Recruiting	`NCT04438408` - National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
Recruiting	`NCT04520165` - Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
Not yet recruiting	`NCT04463836` - Phenotyping Circulating and Lung Resident Eosinophils in Severe Asthma (P-CLESA)
Enrolling by invitation	`NCT06421402` - K-HEALTH in AIR - Barcelona Pilot - Cohort
Recruiting	`NCT03377920` - Predictive Value of Spirometric PIF to Produce PIF Rate Needed for the Use of Current DPI's.	N/A
Recruiting	`NCT04565483` - Predictive Signature of Benralizumab Response	Phase 4
Recruiting	`NCT04045587` - International Severe Asthma Registry: Canadian Cohort
Completed	`NCT05616338` - Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)	N/A
Active, not recruiting	`NCT02038374` - Clinico-biological Correlation of Severe Asthma in Children	N/A
Active, not recruiting	`NCT02114034` - Cohort Analysis of Clinical and Biological Severe Childhood Asthma
Recruiting	`NCT06035289` - Register Schweres Asthma - German Asthma Net e.V.
Not yet recruiting	`NCT03532685` - Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up	N/A
Completed	`NCT03931954` - Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients
Recruiting	`NCT03984253` - Swiss Severe Asthma Register
Recruiting	`NCT03435237` - Phenotyping Asthma for Bronchial Thermoplasty
Recruiting	`NCT03476109` - Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.	Phase 4